C10ORF118 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.165000E-01
Normal-vs-Stage2
8.787800E-01
Normal-vs-Stage3
2.148600E-01
Normal-vs-Stage4
5.237200E-01
Stage1-vs-Stage2
3.957800E-01
Stage1-vs-Stage3
1.429380E-01
Stage1-vs-Stage4
6.677800E-01
Stage2-vs-Stage3
2.236600E-01
Stage2-vs-Stage4
1.717780E-01
Stage3-vs-Stage4
1.296630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.466400E-01
Normal-vs-AfricanAmerican
5.262000E-01
Normal-vs-Asian
8.727600E-01
Caucasian-vs-AfricanAmerican
1.279600E-01
Caucasian-vs-Asian
9.624800E-01
AfricanAmerican-vs-Asian
3.205400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.047200E-01
Normal-vs-Female
8.943200E-01
Male-vs-Female
9.183200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.687400E-01
Normal-vs-Age(41-60Yrs)
6.930200E-01
Normal-vs-Age(61-80Yrs)
6.846600E-01
Normal-vs-Age(81-100Yrs)
3.432800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.973200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.258600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.154600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.057600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.333600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.568600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.461000E-01
Normal-vs-Daily Drinker
5.687600E-01
Normal-vs-Weekly Drinker
4.554400E-01
Normal-vs-Occasional Drinker
5.670800E-01
Normal-vs-Social Drinker
9.606600E-01
Non Drinker-vs-Daily Drinker
5.737000E-01
Non Drinker-vs-Weekly Drinker
4.225000E-01
Non Drinker-vs-Occasional Drinker
6.389900E-02
Non Drinker-vs-Social Drinker
6.138600E-01
Daily Drinker-vs-Weekly Drinker
7.749400E-01
Daily Drinker-vs-Occasional Drinker
3.279700E-02
Daily Drinker-vs-Social Drinker
3.511200E-01
Weekly Drinker-vs-Occasional Drinker
3.265500E-02
Weekly Drinker-vs-Social Drinker
2.634800E-01
Occasional Drinker-vs-Social Drinker
2.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.441700E-02
Normal-vs-Grade 2
2.171600E-02
Normal-vs-Grade 3
3.935100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.982000E-01
Grade 1-vs-Grade 3
5.207200E-01
Grade 1-vs-Grade 4
5.441700E-02
Grade 2-vs-Grade 3
5.667000E-01
Grade 2-vs-Grade 4
2.171600E-02
Grade 3-vs-Grade 4
3.935100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.954200E-01
Normal-vs-NonDiabetic
7.667800E-01
Diabetic-vs-NonDiabetic
8.460800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.649200E-01
Normal-vs-NoPancreatitis
8.066600E-01
Pancreatitis-vs-NoPancreatitis
9.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.202600E-01
Normal-vs-N1
8.904600E-01
N0-vs-N1
9.346000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.576600E-01
Normal-vs-TP53-NonMutant
7.128200E-01
TP53-Mutant-vs-TP53-NonMutant
8.325200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
